RecallRadar
FDA · DrugsClass I

Victory Medical Center Pharmacy drug recall: Glutathione

Sterility concernsMicrobial contamination

Key facts

Agency
U.S. Food and Drug Administration (FDA)
Program
Drugs
Classification
Class I
Status
Ongoing
Event ID
99509
Recall initiated
Jul 1, 2026
Classified by FDA
Aug 19, 2026
Posted in Enforcement Report
Aug 19, 2026
Recalling firm
Victory Medical Center Pharmacy
Firm location
Austin, TX, United States
Initiated by
Voluntary: Firm initiated
Firm notified customers by
Telephone
Products in this event
1

What to do

Compare the product, lot or serial numbers below with what you have. If you use a prescription drug or medical device in this recall, talk to your pharmacist or health care provider before you stop using it, and follow the firm's instructions.

View the official FDA record ↗

Reason for recall

Microbial Contamination of Sterile Products - out of specifications results were obtained for bacterial endotoxin.

What the classification means

  • Class I: FDA's most serious category: there is a reasonable probability that using or being exposed to the product will cause serious health problems or death.

About this recall

The firm started this recall on Jul 1, 2026. FDA classified it 49 days later, on Aug 19, 2026. Distribution reported by FDA: USA Nationwide

Recalled products (1)

  • D-0772-2026 Class I Ongoing

    Glutathione (MDV), 200 mg/mL, 30 mL vial, each mL contains Glutathione 200 mg, Ascorbic Acid 20 mg, Benzyl Alcohol 1.5%, Na Hydroxide (Ph Adjust) in sterile water for injection, VMC.

    Codes / lots: Lot # 1984345, 1980571, 1981940, Use Before Date: 08/27/2026.

    Quantity: 91

Source and freshness

Source
U.S. Food and Drug Administration (FDA) Enforcement Report, via the openFDA drug enforcement dataset
Official notice
FDA Enforcement Report, event 99509
Raw record
openFDA API (JSON)
Dataset last updated by FDA
Nov 3, 2026
Imported by RecallRadar
Nov 4, 2026

Enforcement Report entries describe recalls FDA has classified. They are not always the same as a company press release. If something here differs from FDA's record, FDA's record is correct — please tell us.